Affect Therapeutics' $16 million Series A funding round was led by ARTIS Ventures and included participation from AlleyCorp, CityLight, LifeArc Ventures, Samsung Next and What If Ventures. In total, Affect Therapeutics has raised about $26 million, said Kristin Muhlner, co-founder and CEO of the company.
Form DEF 14A TLG Acquisition One Corp For: Jul 27 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Dental care company quip lands $100M in Series B funding and other digital health deals mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Affect raises a seed round to grow its stimulant abuse recovery service
There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech and sometimes even a space startup. But amid the regular flow of funding news, it’s still rare to come across a company raising money to take on addiction with software. So when Affect’s $1 million seed round from AlleyCorp came to my attention, I wanted to learn a bit more.
As someone who went to rehab for alcohol use disorder in what appeared to be a partially renovated middle school where the highest-tech thing that was in our group rooms were
Affect raises a seed round to grow its stimulant abuse recovery service yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.